肿瘤标志物检测在宫颈癌诊断中的价值探析

The value of tumor markers in the diagnosis of cervical cancer

ES评分 0

DOI 10.12208/j.ijmd.20220264
刊名
International Journal of Medicine and Data
年,卷(期) 2022, 6(6)
作者
作者单位

空军杭州特勤疗养中心 浙江杭州 ;

摘要
探究肿瘤标志物检测在宫颈癌诊断中的临床价值。方法 选取我院48例疑似宫颈癌设定为观察组,另选取同期我院48例体检健康者设定为对照组。两组均进行血清肿瘤标志物检测,对其检测结果进行分析对比。结果 观察组CA125、CEA检测结果明显高于对照组,差异均有统计学意义(P<0.05)。将病理检出结果作为金标准,CA125、CEA联合检测结果的准确性、敏感性、特异性均高于CA125、CEA单一检测结果。结论 在宫颈癌患者诊断过程中,采用CA125、CEA联合检测能取得较佳的效果,对其后续治疗可提供有效依据。
Abstract
Objective To explore the clinical value of tumor markers detection in the diagnosis of cervical cancer. Methods 48 cases of suspected cervical cancer in our hospital were selected as the observation group, and 48 cases of healthy people in our hospital were selected as the control group in the same period. Serum tumor markers were detected in both groups, and the results were analyzed and compared. Results The results of CA125 and CEA in the observation group were significantly higher than those in the control group (P<0.05). Taking pathological detection results as the gold standard, the accuracy, sensitivity and specificity of CA125 and CEA combined detection results are higher than those of CA125 and CEA single detection results. Conclusion The combined detection of CA125 and CEA can achieve better results in the diagnosis of cervical cancer patients, and provide effective basis for their follow-up treatment.
关键词
肿瘤标志物;宫颈癌;诊断
KeyWord
Tumor markers; Cervical cancer; diagnosis
基金项目
页码 129-131
  • 参考文献
  • 相关文献
  • 引用本文

黄龑,倪翀*. 肿瘤标志物检测在宫颈癌诊断中的价值探析 [J]. 国际医学与数据杂志. 2022; 6; (6). 129 - 131.

  • 文献评论

相关学者

相关机构